EGFR and hepatocellular carcinoma: It has been revealed that treatment of HCC cells with 600-1000 μM NaHS effectively inhibits migration and invasion in a concentration-dependent fashion through the regulation of epidermal growth factor receptor (EGFR)/ERK/MMP-2 and PTEN/AKT pathways 126.